Navigation Links
NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets

og Scale.

ABOUT INSOMNIA

Insomnia is a sleep disorder whose sufferers experience inadequate or poor quality sleep and report one or more of the following: difficulty initiating sleep, difficulty maintaining sleep, and waking up too early. According to the "2005 Sleep in America Poll," 54% of those surveyed indicated they experience at least one symptom of insomnia a few nights per week. Only approximately 14% of the respondents reported using any sort of sleep-aid therapy. Walsh and Engelhardt (1999) estimated $14 billion is spent each year on the direct costs of insomnia, including pharmaceuticals, healthcare services and hospital and nursing home care. Cowen & Company estimated the total non-benzodiazepine prescription market in the U.S. for the treatment of insomnia in 2006 was approximately $3.4 billion, growing to $3.8 billion by 2011. Ambien(R)/Ambien CR(TM) (zolpidem tartrate) are the dominant products with approximately 80% of the market in 2006. The patent on Ambien(R) has expired and generic products were recently introduced.

ABOUT NOVADEL PHARMA

NovaDel Pharma Inc. is a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed drugs. The Company's proprietary technology offers, in comparison to conventional oral dosage forms, the potential for faster absorption of drugs into the bloodstream leading to quicker onset of therapeutic effects and possibly reduced first pass liver metabolism, which may result in lower doses. Oral sprays eliminate the requirement for water or the need to swallow, potentially improving patient convenience and adherence.

NovaDel's oral spray technology is focused on addressing unmet medical needs for a broad array of existing and future pharmaceutical products. The Company's most advanced oral spray candidates target angina, nausea, insomnia, migraine headaches and disorders of the central nervous system. NovaDel plans to develop these and other product
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:8/29/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) ... District of New Jersey has ... Sandoz, Inc. regarding United Therapeutics, Remodulin ® product.  In ... U.S. Patent No. 6,765,117 is both valid and enforceable ... generic product until the expiration of that patent in ...
(Date:8/29/2014)... 2014 According to the ... Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User ... Gene Synthesis, NGS, DNA, RNAi) - Global Forecast ... Synthesis Market is expected to reach $1,712.1 Million ... at a CAGR of 9.8% from 2014 to ...
(Date:8/29/2014)...  Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... to release its financial results for the fiscal 2014 ... market trading ends on Tuesday, September 9, 2014. ... 4:30 p.m. U.S. EDT on Tuesday, September 9, 2014 ... the Company,s financial results, commercial partnerships, and future outlook.  ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2
... March 24, 2011 When it comes to their ... to a January 2011 survey by the American Association ... losing their natural teeth. One way to help people ... During Root Canal Awareness Week, March 27 – April ...
... 2011 An educational symposium at the American Academy of ... learn more about the landscape of chronic opioid therapy. ... Opioid Therapy and Risk Management" and sponsored by Ameritox, will ... The event will be held Saturday, March 26 at 5:30 ...
Cached Medicine Technology:Dispelling Myths of Root Canals Through Education 2Symposium Highlights Evolving Landscape of Chronic Opioid Therapy 2
(Date:8/30/2014)... Saturday 30 August 2014: The first recommendations on ... pulmonary embolism are published today in new ESC ... by Professor Stavros V. Konstantinides (Germany/Greece) and Professor ... on the diagnosis and management of acute pulmonary ... Journal (1) and on the ESC Website. , ...
(Date:8/29/2014)... Colorado (PRWEB) August 29, 2014 Daily Gossip ... popular such program on the market nowadays. This method promises ... power, with the use of some effective alternative sources for ... known alternative energy sources are wind and solar power. ... is currently easily accessible in an eBook. So, this is ...
(Date:8/29/2014)... August 30, 2014 Cancer is ... ones and caretakers. Author Eddie M. Leung knows the suffering ... or bile duct cancer, a very rare and aggressive ... Changed My Life” (published by Xlibris), he shares a glimpse ... he imparts a survivor’s testimony that this disease can be ...
(Date:8/29/2014)... Everyone dreams about looking absolutely great, ... , According to the latest review published by Daily ... imagined with the right tips and recommendations. , ... an amazingly effective and fast method of looking perfectly. ... program is really efficient when it comes to the ...
(Date:8/29/2014)... According to this latest review published by DailyGossop.org, this is ... it is amazingly effective. In fact, the program is commonly ... , Driver Robot is so popular, as it can ... highly effective in finding the right drivers that users need ... writes in its Driver Robot review that what users need ...
Breaking Medicine News(10 mins):Health News:First recommendations on all new oral anticoagulants in pulmonary embolism published 2Health News:Home Made Energy Review Exposes Simple Method to Access Alternative Energy Sources 2Health News:Eddie M. Leung Shares His Testimony As a Survivor of Cancer 2Health News:Eddie M. Leung Shares His Testimony As a Survivor of Cancer 3Health News:Shapeshifter Yoga Review Reveals Kris Fondran's New Body Shaping and Fat Loss Program 2Health News:Driver Robot Review Exposes Popular Hardware Detection Tool 2
... Urology (EAU) and Europa Uomo, the European,advocacy movement ... into an,affiliated partnership as part of their long-term ... with regards to urological diseases. Professor Per-Anders Abrahamsson, ... affiliated partnership, Europa Uomo will gain access to ...
... asked to inhibit their response to a "cocaine-cues" video, ... activity in brain regions linked to drug craving, according ... Energy,s Brookhaven National Laboratory. The results, to be published ... that clinical interventions designed to strengthen these inhibitory responses ...
... , ... Old Eats Octopus," gives mealtime tips for raising children who love to eat everything. ... (PRWEB) November 30, 2009 -- ... as a short-order cook at mealtime? Three new short online videos – one focusing ...
... ... and the body in his new book "Healing Heart to Soul: One Doctor’s Journey of ... ... let go of negative emotions, whether caused by us or inflicted by others, can weigh ...
... , Red Cross offers online giving catalog to help families ... Nov. 30 In spite of the economic downturn, Americans are entering ... percent planning to dig deep into their own wallets to support charities ... of buying them a gift, according to a new survey for the ...
... MINNEAPOLIS, Nov. 30 A new study has found that 27% ... intention to shop for and possibly switch their Medicare coverage. ... past four years, the "intention to switch" measure has been a ... with some intention to switch actually will leave their current insurer ...
Cached Medicine News:Health News:Brain scan study shows cocaine abusers can control cravings 2Health News:Brain scan study shows cocaine abusers can control cravings 3Health News:New Videos Help Parents of Picky Eaters 2Health News:New Videos Help Parents of Picky Eaters 3Health News:Healing from the Inside Out: Compelling New Book Explores the Intricate Connection between Body, Soul, and Better Health 2Health News:American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn 2Health News:American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn 3Health News:More Seniors Considering Health Insurance Switch 2
... a combination of innovative design, consistently reliable ... I-125 implant an ideal choice for your ... every BrachySource I-125 implant order is backed ... required by clinicians who must meet the ...
... BrachySource iodine-125 implant is a combination of ... visibility that makes BrachySource I-125 implant an ... can be confident that every BrachySource I-125 ... management services which is required by clinicians ...
The silicone Tractfinder provides excellent fluoroscopic visualization. Manipulation of the movable core guidewire flexes the tapered proximal tip for maximum control in negotiating a tortuous ureter...
... Used for temporary internal drainage from the ... of a stricture. The segment with no ... lumen while preventing ingrowth of the ureteral ... peel-open packages. Intended for one-time use. CAUTION: ...
Medicine Products: